Skip to main content
OpenTrials

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

1,103 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Dyskinesias trial results

Completed

Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease

NCT04400331

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Neurocrine Clinical Site Birmingham, Alabama, United States
  • Neurocrine Clinical Site Little Rock, Arkansas, United States
  • Neurocrine Clinical Site La Jolla, California, United States
  • Neurocrine Clinical Site Aurora, Colorado, United States
View all 34 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

NCT05358717

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • University of California, San Diego La Jolla, California, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • The University of Texas Health Science Center at Houston; McGovern Medical School Houston, Texas, United States
  • University of Washington Department of Neurology Seattle, Washington, United States
View all 28 locations
View Trial Details
Completed

Dance and Huntington Disease

NCT01842919

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Institut du cerveau et de la moelle épinière (ICM), CHU Pitié Salpêtrière Paris, France
View Trial Details
Completed

Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder

NCT04276883

Conditions
Aberrant Motor Behavior in Dementia, Agitation Associated With Bipolar Disorder, Agitation,Psychomotor, +14 more
Locations
  • BioXcel Clinical Research Site Little Rock, Arkansas, United States
  • BioXcel Clinical Research Site Cerritos, California, United States
  • BioXcel Clinical Research Site Culver City, California, United States
  • BioXcel Clinical Research Site Long Beach, California, United States
View all 15 locations
View Trial Details
Completed

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

NCT04268303

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Behavior, +16 more
Locations
  • BioXcel Clinical Research Site Little Rock, Arkansas, United States
  • BioXcel Clinical Research Site Cerritos, California, United States
  • BioXcel Clinical Research Site Culver City, California, United States
  • BioXcel Clinical Research Site Long Beach, California, United States
View all 15 locations
View Trial Details

Related conditions